首页 正文

Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children

{{output}}
Background: B-cell acute lymphoblastic leukemia (B-cell ALL) is the most common childhood cancer. Despite a high overall cure rate, relapsed B-cell ALL remains a leading cause of cancer-related death among children. The addition ... ...